| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2009 | WO2009104205A1 Delayed release formulation of chloride channel activator |
| 08/27/2009 | WO2009104198A2 Metal conjugates of indole 3- aldehyde azine and its derivatives and uses thereof |
| 08/27/2009 | WO2009104167A1 A substance or composition for the treatment of cancer |
| 08/27/2009 | WO2009104159A1 Oxazolidinone derivatives |
| 08/27/2009 | WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 08/27/2009 | WO2009104152A1 Combination treatment for ovarian cancer |
| 08/27/2009 | WO2009104150A1 Combination comprising bosentan for treating ovarian cancer |
| 08/27/2009 | WO2009104149A1 Combination comprising paclitaxel for treating ovarian cancer |
| 08/27/2009 | WO2009104100A2 Antibody combinations, and methods of making and using same |
| 08/27/2009 | WO2009104080A2 Cns pharmaceutical compositions and methods of use |
| 08/27/2009 | WO2009104045A1 Ophthalmic gemifloxacin compositions for the treatment of ocular infections |
| 08/27/2009 | WO2009104027A1 Therapeutic application of triciclic aromatic and saturated benzo(4,5)thieno-(2,3-d)pyrimidine derivates, as well as their therapeutically acceptable salts |
| 08/27/2009 | WO2009104026A1 Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use |
| 08/27/2009 | WO2009104021A2 Novel polymorphs and processes for their preparation |
| 08/27/2009 | WO2009104019A1 Combination therapy 238 |
| 08/27/2009 | WO2009103966A1 Bicyclylaryl-aryl-amine compounds and their use |
| 08/27/2009 | WO2009103959A2 Medicament |
| 08/27/2009 | WO2009103953A1 Treatment of energy utilization disease |
| 08/27/2009 | WO2009103950A1 Fluorinated pyridin-4-0nes |
| 08/27/2009 | WO2009103932A1 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain |
| 08/27/2009 | WO2009103901A2 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas |
| 08/27/2009 | WO2009103875A1 Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same |
| 08/27/2009 | WO2009103821A2 Means for treating virus infections |
| 08/27/2009 | WO2009103808A2 Methods and compositions for increasing rna interference |
| 08/27/2009 | WO2009103807A1 Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation |
| 08/27/2009 | WO2009103788A1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 08/27/2009 | WO2009103778A1 Compounds and methods |
| 08/27/2009 | WO2009103755A1 Novel use of 3,3'-diindolylmethane |
| 08/27/2009 | WO2009103754A2 Novel use of 3,3'-diindolylmethane |
| 08/27/2009 | WO2009103739A1 Heterocyclic inhibitors of stearoyl-coa desaturase |
| 08/27/2009 | WO2009103719A1 Substituted 4-(indol-3-yl)quinazolines and use and production thereof |
| 08/27/2009 | WO2009103710A1 Substituted 4-hydroxy-n- (4-hydroxyphenyl) indoles as estrogenic agents |
| 08/27/2009 | WO2009103652A1 Modulators for amyloid beta |
| 08/27/2009 | WO2009103626A1 4, 5-dihydro-oxazol-2-yl amine derivatives |
| 08/27/2009 | WO2009103552A1 Substituted indole derivatives |
| 08/27/2009 | WO2009103534A2 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof |
| 08/27/2009 | WO2009103494A2 Sgk1 as a therapeutic and diagnostic target for carcinomatous diseases |
| 08/27/2009 | WO2009103493A1 Sgk1 as a therapeutic and diagnostic target for viral diseases |
| 08/27/2009 | WO2009103487A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 08/27/2009 | WO2009103484A1 Sgk1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas |
| 08/27/2009 | WO2009103478A1 Pyridone and pyridazinone derivatives as mch antagonists |
| 08/27/2009 | WO2009103476A1 Antitumoral agents with a benzophenanthridine structure and formulations containing them |
| 08/27/2009 | WO2009103440A1 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
| 08/27/2009 | WO2009103439A1 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 08/27/2009 | WO2009103432A2 Covalently binding imaging probes |
| 08/27/2009 | WO2009103427A2 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation |
| 08/27/2009 | WO2009103360A1 Polyisoprenoid epoxides useful for decreasing cholesterol and/or increasing coenzyme q biosynthesis |
| 08/27/2009 | WO2009103334A1 Folates, compositions and uses thereof |
| 08/27/2009 | WO2009103333A1 Process for the diastereoisomeric resolution of 5-methyltetrahydrofolic acid |
| 08/27/2009 | WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 08/27/2009 | WO2009103209A1 Stable s-(-)- nadifloxacin-l-arginine composition, its preparation method and use |
| 08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
| 08/27/2009 | WO2009103176A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions |
| 08/27/2009 | WO2009103166A1 Treatment of neural diseases or conditions |
| 08/27/2009 | WO2009103164A1 Anti-obesity compositions comprising orlistat and various natural products |
| 08/27/2009 | WO2009103150A1 Method for treating migraine headaches |
| 08/27/2009 | WO2009103139A1 Soap kit and method for women's intimate hygiene and soap composition for the menstrual period |
| 08/27/2009 | WO2009103123A1 Dendrimeric enzyme inhibitors |
| 08/27/2009 | WO2009103114A1 Method for producing a bioactive glucan product substantially free of endotoxin contamination |
| 08/27/2009 | WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009084017A3 Taste-masked orally disintegrating tablets of memantine hydrochloride |
| 08/27/2009 | WO2009083272A3 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES |
| 08/27/2009 | WO2009082720A3 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists |
| 08/27/2009 | WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 08/27/2009 | WO2009082038A3 Ampa receptor antagonists and zonisamide for epilepsy |
| 08/27/2009 | WO2009081174A3 Anti - retroviral combination |
| 08/27/2009 | WO2009080693A3 Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker |
| 08/27/2009 | WO2009080691A3 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
| 08/27/2009 | WO2009080226A3 Heterocyclic pyrazole-carboxamides as p2y12 antagonists |
| 08/27/2009 | WO2009079405A3 Assessing treatment compliance |
| 08/27/2009 | WO2009076455A3 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 08/27/2009 | WO2009076200A3 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
| 08/27/2009 | WO2009075835A8 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 08/27/2009 | WO2009074677A3 Pyrazolotriazines |
| 08/27/2009 | WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds |
| 08/27/2009 | WO2009067674A3 Polymorphs of sunitinib base and processes for preparation thereof |
| 08/27/2009 | WO2009066035A3 Combination between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor |
| 08/27/2009 | WO2009065395A3 Novel use of omega-3-fatty acid(s) |
| 08/27/2009 | WO2009064752A3 Heterocyclic derivatives as modulators of ion channels |
| 08/27/2009 | WO2009064195A3 Reduced sexual maturation in fish |
| 08/27/2009 | WO2009063215A3 Use of crth2 antagonist compounds |
| 08/27/2009 | WO2009063202A3 Use of crth2 antagonist compounds |
| 08/27/2009 | WO2009061906A3 Treating protein misfolding diseases |
| 08/27/2009 | WO2009051659A3 Therapeutic sirna molecules for reducing vegfr1 expression in vitro and in vivo |
| 08/27/2009 | WO2009047303A3 Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
| 08/27/2009 | WO2009045543A8 Treatment of conditions related to shock |
| 08/27/2009 | WO2009034409A3 Pharmaceutical compositions of rhein or diacerein |
| 08/27/2009 | WO2009033667A3 Use of a peptide as a therapeutic agent |
| 08/27/2009 | WO2009033039A8 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 08/27/2009 | WO2009026328A3 Methods of delivery of agents to leukocytes and endothelial cells |
| 08/27/2009 | WO2009026248A3 Hydrazide, amide, phthalimide and phthalhydrazide analogs as inhibitors of retroviral integrase |
| 08/27/2009 | WO2009020894A3 RNAι-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA |
| 08/27/2009 | WO2009012280A3 Benzimidazole poly(adp-ribose)polymerase inhibitors |
| 08/27/2009 | WO2009010974A3 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 08/27/2009 | WO2008154905A3 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid |
| 08/27/2009 | WO2008142513A3 Phosphate-modified oligonucleotide analogs with immunostimulatory activity |
| 08/27/2009 | WO2008135819A8 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide |
| 08/27/2009 | WO2008121348A8 Peripheral opioid receptor antagonists and uses thereof |
| 08/27/2009 | WO2008116145A3 Soluble epoxide hydrolase inhibitors |